RXST Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Rxsight Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 61.68 USD 3.44%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast RXST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXST is 63.97 USD with a low forecast of 61.61 USD and a high forecast of 68.25 USD.

RXST Lowest Forecast

Wall Street Target

RXST Average Forecast

Wall Street Target

RXST Highest Forecast

Wall Street Target

0% Downside

4% Upside

11% Upside

The latest public price target was made on Dec 13, 2023 by Lawrence Biegelsen from Wells Fargo , who expects RXST stock to drop by 32% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Lawrence Biegelsen Wells Fargo	42 USD Downside 32%	4 months ago Dec 13, 2023	Wells Fargo Upgrades RxSight Inc. (RXST) to Overweight StreetInsider
David Saxon Needham	34 USD Downside 45%	9 months ago Jul 12, 2023	RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+ Benzinga

Price Target	42 USD
Upside/Downside	32%

Price Target	34 USD
Upside/Downside	45%

Merit Medical Systems Inc

21% Upside

Top Glove Corporation Bhd

8% Downside

DENTSPLY SIRONA Inc

34% Upside

Winner Medical Co Ltd

62% Upside

Merit Medical Systems Inc

21% Upside

Top Glove Corporation Bhd

8% Downside

DENTSPLY SIRONA Inc

34% Upside

Winner Medical Co Ltd

62% Upside

SDI Ltd

37% Upside

Shanghai Kindly Medical Instruments Co Ltd

28% Upside

InspireMD Inc

130% Upside

Kangji Medical Holdings Ltd

41% Upside

Revenue
Forecast

For the last 3 years the compound annual growth rate for Rxsight Inc's revenue is 82%. The projected CAGR for the next 3 years is 34%.

82%

34%

-1%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-7%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-32%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for RXST is 63.97 USD with a low forecast of 61.61 USD and a high forecast of 68.25 USD.

For the last 3 years the compound annual growth rate for Rxsight Inc's revenue is 82%. The projected CAGR for the next 3 years is 34%.

Join more than 134,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.